Enzo Life Sciences
Product line based on proprietary nucleic acid labelling technologies; Develops, manufactures and markets products to medical and biological research laboratories
Enzo Life Sciences was founded in 1976 by Dr. Elazar Rabbani, Shahram Rabbani and Barry Weiner. Enzo Life Sciences is the wholly-owned subsidiary of Enzo Biochem.
Dr. Elazar Rabbani (CEO)
Shahram K. Rabbani (COO, Treasurer)
Herbert B. Bass (VP, Finance)
Dr. Elazar Rabbani (Chairman)
John Sias
John DeLucca
Irwin Gerson
Melvin Lazar
Marcus A. Conant
60 Executive Blvd.
Farmingdale, NY 11735
USA
Phone: +1-631-694-7070
Fax: +1-631-694-7501
The BioArray™ HighYield™ RNA Transcript Labelling kit provides for the production of biotin labelled RNA for nucleic acid arrays.
The BioArray™ CGH Labeling System is a “Comparative Genomic Hybridization” labelling system for Cy3 and Cy5 labelled DNA.
The GeneBeam™ First Strand cDNA Labelling kit is designed for the preparation of Cyanine-3 and Cyanine-5 labelled cDNA for nucleic acid arrays.
Related patents
- Linear amplification of specific nucleic acid sequences
- Detecting the presence of specific target nucleic acid sequences through stem-loop formation
- REAL TIME NUCLEIC ACID DETECTION METHOD AND COMPOSITION
- Process for preparing novel cyanine dye labeling reagents
- Labeling reagents comprising aphenylic analogs of rhodamine dyes
- Novel chemiluminescent reagents
- Heterodimeric dye composition
- Novel dye labeling composition
- Process for detecting the presence or quantity of enzymatic activity in a sample
- Process for detecting the presence or quantity of enzymatic activity in a sample
- Multisignal labeling reagents, processes and uses therefor
- Composition of matter comprising library of first nucleic acid analyte copies
- Novel compositions and processes for analyte detection, quantification and amplification
- Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids